Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose

od Jilg, Stefanie, Hauch, Richard T., Kauschinger, Johanna, Buschhorn, Lars, Odinius, Timo O., Dill, Veronika, Müller-Thomas, Catharina, Herold, Tobias, Prodinger, Peter M., Schmidt, Burkhard, Hempel, Dirk, Bassermann, Florian, Peschel, Christian, Götze, Katharina S., Höckendorf, Ulrike, Haferlach, Torsten, Jost, Philipp J.
Wydane w Exp Hematol Oncol (2019)